PAIN
Volume 153, Issue 3 , Pages 532-539 , March 2012

Metallothionein deficiency in the injured peripheral nerves of complex regional pain syndrome as revealed by proteomics

  • Gosuke Oki

      Affiliations

    • Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo, Japan
    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Takuro Wada

      Affiliations

    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Kosuke Iba

      Affiliations

    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Hikono Aiki

      Affiliations

    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Kouichi Sasaki

      Affiliations

    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Shin-ichi Imai

      Affiliations

    • Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Hitoshi Sohma

      Affiliations

    • Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo, Japan
    • Department of Educational Development, Sapporo Medical University Center for Medical Education, Sapporo, Japan
    • ,
  • Kayo Matsumoto

      Affiliations

    • Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Mami Yamaguchi

      Affiliations

    • Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Mineko Fujimiya

      Affiliations

    • Department of Anatomy, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Toshihiko Yamashita

      Affiliations

    • Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Yasuo Kokai

      Affiliations

    • Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo, Japan
    • Corresponding Author InformationCorresponding author. Address: Department of Biomedical Engineering, Sapporo Medical University School of Medicine, S1W17, Chuo-ku, Sapporo 060-8556, Japan. Tel.: +81 11 611 2111x2520; fax: +81 615 2315.

Received 6 July 2011 ,Revised 5 October 2011 ,Accepted 7 November 2011.

References 

  1. Abel J, de Ruiter N. Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicol Lett. 1989;47:191–196
  2. Aivado M, Spentzos D, Germing U, Alterovitz G, Meng XY, Grall F, et al. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc Natl Acad Sci USA. 2007;104:1307–1312
  3. Bell SG, Vallee BL. The metallothionein/thionein system: an oxidoreductive metabolic zinc link. ChemBioChem. 2009;10:55–62
  4. Chung JM. The role of reactive oxygen species (ROS) in persistent pain. Mol Interv. 2004;4:248–250
  5. Chung RS, Penkowa M, Dittmann J, King CE, Bartlett C, Asmussen JW, et al. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem. 2008;283:15349–15358
  6. Chung RS, Vickers JC, Chuah MI, West AK. Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury. J Neurosci. 2003;23:3336–3342
  7. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60:540–551
  8. Ebadi M, Sharma S. Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Exp Biol Med. 2006;231:1576–1583
  9. Eibl JK, Abdallah Z, Ross GM. Zinc-metallothionein: a potential mediator of antioxidant defence mechanisms in response to dopamine-induced stress. Can J Physiol Pharmacol. 2010;88:305–312
  10. Eisenberg E, Shtahl S, Geller R, Reznick AZ, Sharf O, Ravbinovich M, et al. Serum and salivary oxidative analysis in complex regional pain syndrome. Pain. 2008;138:226–232
  11. Fitzgerald M, Nairn P, Bartlett CA, Chung RS, West AK, Beazley LD. Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp Brain Res. 2007;183:171–180
  12. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J. Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol. 2002;173:114–128
  13. Goncalves A, Bertucci F. Clinical application of proteomics in breast cancer: state of the art and perspectives. Med Princ Pract. 2011;20:4–18
  14. Gotow T. Neurofilaments in health and disease. Med Electron Microsc. 2000;33:173–199
  15. Harden RN, Bruehl SP. Diagnosis of complex regional pain syndrome: signs, symptoms, and new empirically derived diagnostic criteria. Clin J Pain. 2006;22:415–419
  16. Hidalgo J, Penkowa M, Espejo C, Martinez-Caceres EM, Carrasco J, Quintana A, et al. Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation. Exp Biol Med. 2006;231:1450–1458
  17. Hori T, Naishiro Y, Sohma H, Suzuki N, Hatakeyama N, Yamamoto M, et al. CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease. Blood. 2008;111:4403–4412
  18. Hu HD, Ye F, Zhang DZ, Hu P, Ren H, Li SL. ITRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells. J Biomed Biotechnol. 2010;2010:571343
  19. Inoue K, Takano H, Shimada A, Satoh M. Metallothionein as an anti-inflammatory mediator. Mediat Inflamm. 2009;2009:426214
  20. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413:203–210
  21. Kerlavage A, Bonazzi V, di Tommaso M, Lawrence C, Li P, Mayberry F, et al. The Celera Discovery System™. Nucleic Acids Res. 2002;30:129–136
  22. Kim HK, Park SK, Zhou JL, Taglialatela G, Chung K, Coggeshall RE, et al. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain. 2004;111:116–124
  23. Koch A, Zacharowski K, Boehm O, Stevens M, Lipfert P, von Giesen HJ, et al. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res. 2007;56:32–37
  24. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147:S232–S240
  25. Målen H, Pathak S, Søfteland T, de Souza GA, Wiker HG. Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv. BMC Microbiol. 2010;10:132
  26. Mizzen CA, Cartel NJ, Yu WH, Fraser PE, McLachlan DR. Sensitive detection of metallothioneins-1, -2 and -3 in tissue homogenates by immunoblotting: a method for enhanced membrane transfer and retention. J Biochem Biophys Methods. 1996;32:77–83
  27. Naik AK, Tandan SK, Dudhgaonkar SP, Jadhav SH, Kataria M, Prakash VR, et al. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats. Eur J Pain. 2006;10:573–579
  28. Pedersen MO, Jensen R, Pedersen DS, Skjolding AD, Hempel C, Maretty L, et al. Metallothionein-I+II in neuroprotection. BioFactors. 2009;35:315–325
  29. Penkowa M, Camats J, Giralt M, Molinero A, Hernandez J, Carrasco J, et al. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression. Glia. 2003;42:287–306
  30. Penkowa M, Carrasco J, Giralt M, Molinero A, Hernandez J, Campbell IL, et al. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice. J Cereb Blood Flow Metab. 2000;20:1174–1189
  31. Penkowa M, Hidalgo J. Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis. Glia. 2000;32:247–263
  32. Penkowa M, Hidalgo J. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE). Exp Neurol. 2001;170:1–14
  33. Penkowa M, Hidalgo J. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J Neurosci Res. 2003;72:574–586
  34. Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci. 2002;22:8790–8796
  35. Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med. 2010;16:1267–1276
  36. Roher AE, Maarouf CL, Sue LI, Hu Y, Wilson J, Beach TG. Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease. Biomarkers. 2009;14:493–501
  37. Scheede-Bergdahl C, Penkowa M, Hidalgo J, Olsen DB, Schjerling P, Prats C, et al. Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes. 2005;54:3089–3094
  38. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–1368
  39. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996;68:850–858
  40. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics. 2007;6:1638–1655
  41. Shinoda K, Tomita M, Ishihama Y. EmPAI Calc—for the estimation of protein abundance from large-scale identification data by liquid chromatography–tandem mass spectrometry. Bioinformatics. 2010;26:576–577
  42. Stankovic RK. Atrophy of large myelinated axons in metallothionein-I, II knockout mice. Cell Mol Neurobiol. 2005;25:943–953
  43. Stankovic RK, Li Z. Decreased neurofilament density in large myelinated axons of metallothionein-I, II knockout mice. Neurosci Lett. 2006;402:1–6
  44. Stanton-Hicks M, Janig W, Hassenbusch S, Haddox JD, Boas R, Wilson P. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127–133
  45. de Tran QH, Duong S, Bertini P, Finlayson RJ. Treatment of complex regional pain syndrome: a review of the evidence. Can J Anaesth. 2010;57:149–166
  46. van Lookeren Campagne M, Thibodeaux H, van Bruggen N, Cairns B, Gerlai R, Palmer JT, et al. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc Natl Acad Sci USA. 1999;96:12870–12875
  47. Yamaguchi M, Kokai Y, Imai S, Utsumi K, Matsumoto K, Honda H, et al. Investigation of annexin A5 as a biomarker for Alzheimer’s disease using neuronal cell culture and mouse model. J Neurosci Res. 2010;88:2682–2692
  48. Yamashita T, Ishii S, Usui M. Pain relief after nerve resection for post-traumatic neuralgia. J Bone Joint Surg. 1998;80:499–503
  49. Zougman A, Pilch B, Podtelejnikov A, Kiehntopf M, Schnabel C, Kumar C, et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res. 2008;7:386–399

PII: S0304-3959(11)00684-1

doi: 10.1016/j.pain.2011.11.008

PAIN
Volume 153, Issue 3 , Pages 532-539 , March 2012

Article Tools

* Image Usage & Resolution